Name | Valtrate |
Synonyms | Valtrate ValtratuM 18296-44-1 VALTRATE(P) ValepotriatuM Valtrate [INN] Halazuchrome B HalazuchroMe B VALTRATE(P)(PLEASE CALL) (1S,7R)-4-Acetoxymethyl-6,7aα-dihydrospiro[cyclopenta[c]pyran-7(1H),2'-oxirane]-1α,6α-diol 1,6-bis(3-methylbutanoate) (1S,6S,7R,7aS)-4-(Acetoxymethyl)-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate) (1S,6S,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate) (1S,6S,7R,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate) butanoic acid, 3-methyl-, (1S,6S,7R,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydrospiro[cyclopenta[c]pyran-7(1H),2'-oxirane]-1,6-diyl ester (1S-(1a,6a,7b,7aa))-3-Methylbutanoic Acid 4-((Acetyloxy)methyl)-6,7a-dihydrospiro(cyclopenta[c]pyran-7(1H),2'-oxirane)-1,6-diyl Ester [(1S,6S,7aS)-4-(Acetyloxymethyl)-1-(3-methylbutanoyloxy)spiro[6,7a-dihydro-1H-cyclopenta[c]pyran-7,2'-oxirane]-6-yl] 3-methylbutanoate |
CAS | 18296-44-1 |
EINECS | 242-174-2 |
InChI | InChI=1/C22H30O8/c1-12(2)6-18(24)29-17-8-16-15(9-26-14(5)23)10-27-21(20(16)22(17)11-28-22)30-19(25)7-13(3)4/h8,10,12-13,17,20-21H,6-7,9,11H2,1-5H3/t17-,20+,21-,22?/m0/s1 |
Molecular Formula | C22H30O8 |
Molar Mass | 422.47 |
Density | 1.22±0.1 g/cm3(Predicted) |
Boling Point | 525.9±50.0 °C(Predicted) |
Specific Rotation(α) | +172.7 (MeOH) |
Flash Point | 226.5°C |
Solubility | Soluble in methanol, ethanol, DMSO and other organic solvents |
Vapor Presure | 3.75E-11mmHg at 25°C |
Appearance | Yellow liquid |
Color | Pale Brown to Dark Yellow to Sticky |
Storage Condition | Refrigerator |
Refractive Index | 1.528 |
MDL | MFCD00868024 |
Physical and Chemical Properties | Yellow liquid, soluble in methanol, ethanol, DMSO and other organic solvents, derived from spider fragrance, valerian. |
In vivo study | Valepotriateshowed significant anti-epileptic activity against MES- and PTZ-induced epilepsy at doses of 5, 10, and 20 mg/kg, and ED50values for MES- and PTZ-induced epilepsy were 7.84 and 7.19 mg/kg, respectively. Furthermore,valepotriate(10 and 20 mg/kg) can significantly prolong sleeping time and shorten the latency time on the pentobarbital sodium-induced sleeping time test. Furthermore,valepotriate(5, 10, and 20 mg/kg) could significantly up-regulate the expression of GABAA, GAD65, and Bcl-2 and down-regulate the expression of caspase-3, but had no significant effect on the expression of GABAB. |
HS Code | 29329990 |
biological activity | Valepotriate, isolated from Valeriana jatamansi, has anti-epileptic and anti-cancer activities. |
in vivo study | Valepotriateshowed significant anti-epileptic activity against MES- and PTZ-induced epilepsy at doses of 5, 10, and 20 mg/kg, and ED50values for MES- and PTZ-induced epilepsy were 7.84 and 7.19 mg/kg, respectively. Furthermore,valepotriate(10 and 20 mg/kg) can significantly prolong sleeping time and shorten the latency time on the pentobarbital sodium-induced sleeping time test. Furthermore,valepotriate(5, 10, and 20 mg/kg) could significantly up-regulate the expression of GABAA, GAD65, and Bcl-2 and down-regulate the expression of caspase-3, but had no significant effect on the expression of GABAB. |
chemical properties | yellow liquid, soluble in organic solvents such as methanol, ethanol, DMSO, etc., derived from spider fragrance and valerian. |
use | valerian triester has anti-tumor and anti-senile dementia effects. used for content determination/identification/pharmacological experiment, etc. |